These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16048825)

  • 1. Profiles of club drug users in treatment.
    Maxwell JC; Spence RT
    Subst Use Misuse; 2005; 40(9-10):1409-26. PubMed ID: 16048825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
    Gahlinger PM
    Am Fam Physician; 2004 Jun; 69(11):2619-26. PubMed ID: 15202696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brief overview of the clinical pharmacology of "club drugs".
    Britt GC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise of club drugs in a heroin society: the case of Hong Kong.
    Joe Laidler KA
    Subst Use Misuse; 2005; 40(9-10):1257-78. PubMed ID: 16048816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    McCaughan JA; Carlson RG; Falck RS; Siegal HA
    Subst Use Misuse; 2005; 40(9-10):1503-23. PubMed ID: 16048830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
    Wu LT; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2006 Sep; 84(1):102-13. PubMed ID: 16483730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of primary amphetamine users in Sweden: a criminal justice population examined with the Addiction Severity Index.
    Hakansson A; Schlyter F; Berglund M
    Eur Addict Res; 2009; 15(1):10-8. PubMed ID: 19052458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rave drugs: pharmacological considerations.
    Klein M; Kramer F
    AANA J; 2004 Feb; 72(1):61-7. PubMed ID: 15098519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Club drugs: reasons for and consequences of use.
    Parks KA; Kennedy CL
    J Psychoactive Drugs; 2004 Sep; 36(3):295-302. PubMed ID: 15559677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coerced treatment for methamphetamine abuse: differential patient characteristics and outcomes.
    Brecht ML; Anglin MD; Dylan M
    Am J Drug Alcohol Abuse; 2005; 31(2):337-56. PubMed ID: 15912720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Party drugs: properties, prevalence, patterns, and problems.
    Maxwell JC
    Subst Use Misuse; 2005; 40(9-10):1203-40. PubMed ID: 16048814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
    Wallace C; Galloway T; McKetin R; Kelly E; Leary J
    Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol use and risk taking among regular ecstasy users.
    Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J
    Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).
    Brecht ML; Greenwell L; Anglin MD
    J Subst Abuse Treat; 2005 Dec; 29(4):295-306. PubMed ID: 16311182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.